Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

The risk‐benefit ratio associated with the use of repurposed drugs to treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)‐related infectious coronavirus disease 2019 (COVID‐19) is complicated because benefits are awaited, not proven. A thorough literature search was conducted to sourc...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaud, Veronique, Dow, Pamela, Al Rihani, Sweilem B., Deodhar, Malavika, Arwood, Meghan, Cicali, Brian, Turgeon, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877829/
https://www.ncbi.nlm.nih.gov/pubmed/32888379
http://dx.doi.org/10.1111/cts.12882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877829/
https://www.ncbi.nlm.nih.gov/pubmed/32888379
http://dx.doi.org/10.1111/cts.12882

Ejemplares similares